Abstract
Pseudohypoglycemia is defined as a patient having apparent hypoglycemia. We describe these syndromes as pseudohypoglycemia type 1 (PHG-1) and pseudohypoglycemia type 2 (PHG-2), respectively. PHG-1 usually refers to when the individual may be displaying symptoms suggestive of hypoglycemia, but the plasma sugar levels are greater than 70 mg/dL. Patients with diabetes and chronic hyperglycemia can present with primarily adrenergic symptoms of hypoglycemia at relatively higher serum glucose levels during periods of aggressive glucose control, sometimes labeled as relative hypoglycemia. However, we can extend the definition to also include a variety of patients presenting with sugar values below 70 mg/dL but no symptoms of hypoglycemia. This scenario could be labeled as pseudohypoglycemia type 2 (PHG-2), with minimal symptoms. For PHG-2, one must always rule out technical/methodological errors first. Increased glucose utilization or extraction peripherally via erythrocytes or leucocytes must also be considered. A careful history and understanding glucose measurement and glucose metabolism will greatly help the clinician manage these phenomena.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Macleod JJR. The control of carbohydrate metabolism. Bull Johns Hopkins Hosp. 1934;54:79–139.
Cannon WB, Mclver MA, Bliss SW. Studies on the conditions of activity in endocrine glands. XIII. A sympathetic and adrenal mechanism for mobilizing sugar in hypoglycemia. Am J Physiol. 1924;69:46–66.
Himwich HE. A review of hypoglycemia, its physiology and pathology, symptomatology, and treatment. Am J Dig Dis. 1944;11(1):1.
Dalal BI, Brigden ML. Factitious biochemical measurements resulting from hematologic conditions. Am J Clin Pathol. 2009;131(2):195–204.
Theofilogiannakos EK, Giannakoulas G, Ziakas A, Karvounis HI, Styliadis IH. Pseudohypoglycemia in a patient with the Eisenmenger syndrome. Ann Intern Med. 2010;152(6):407.
Wang EY, Patrick L, Connor DM. Blind obedience and an unnecessary workup for hypoglycemia: a teachable moment. JAMA Intern Med. 2018;178(2):279–80.
Klonoff DC, Alexander Fleming G, Muchmore DB, Frier BM. Hypoglycemia evaluation and reporting in diabetes: importance for the development of new therapies. Diabetes Metab Res Rev. 2017;33(5):e2883.
Shaefer C, Hinnen D, Sadler C. Hypoglycemia and diabetes: increased need for awareness. Curr Med Res Opin. 2016;32(9):1479–86.
Rushakoff RJ, Lewis SB. Case of pseudohypoglycemia. Diabetes Care. 2001;24(12):2157–8.
Khoury M, Yousuf F, Martin V, Cohen R. Pseudohypoglycemia: a cause for unreliable finger-stick glucose measurements. Endocr Pract. 2008;14(3):337–9.
Fanelli CG, Lucidi P, Bolli GB, Porcellati F. Hypoglycemia. In: Diabetes complications, comorbidities, and related disorders. Cham: Springer; 2018. p. 617–54.
Spanakis EK, Cryer PE, Davis SN. Hypoglycemia during therapy of diabetes. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc; 2018.
Fabrykant M. Pseudohypoglycemic reactions in insulin-treated diabetics: etiology, laboratory aids and therapy. J Am Geriatr Soc. 1964;12(3):221–38.
Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971–80. Published 2009.
Kadhem S, Ebrahem R, Ahmed B, Mortada R. Unreliable fingerstick glucose measurement in systemic sclerosis. AACE Clin Case Rep. 2016;2(4):e367–9.
Crevel E, Ardigo S, Perrenoud L, Vischer UM. Acrocyanosis as a cause of pseudohypoglycemia. J Am Geriatr Soc. 2009;57(8):1519–20.
Kagawa D, Ando S, Ueda T, Nakamura T, Domae N, Uchino H. A case of chronic myelogenous leukemia with pseudohypoglycemia: correlation between leukocyte counts and blood glucose levels. [Rinsho ketsueki] Jpn J Clin Hematol. 1987;28(10):1790–4.
Wenk RE, Yoho S, Bengzon A. Pseudohypoglycemia with monoclonal immunoglobulin M. Arch Pathol Lab Med. 2005;129(4):454–5.
Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3(4):903–13. Published 2009.
Liang Y, Rice MJ. Assessing glucose meter accuracy: the details matter! Anesthesiology. 2018;128(5):1044–5.
Thabit H, Hovorka R. Bridging technology and clinical practice: innovating inpatient hyperglycemia management in non-critical care settings. Diabet Med. 2018;35(4):460–71.
Li M, Zhou J, Bao YQ, Lu W, Jia WP. Prediction of nocturnal hypoglycemia with bedtime glucose level during continuous subcutaneous insulin infusion in type 2 diabetics. Zhonghua Yi Xue Za Zhi. 2010;90:2962–6.
Ma XJ, Zhou J. Using continuous glucose monitoring for patients with hypoglycemia. In: Continuous glucose monitoring. Singapore: Springer; 2018. p. 121–8.
Peyser TA, Nakamura K, Price D, Bohnett LC, Hirsch IB, Balo A. Hypoglycemic accuracy and improved low glucose alerts of the latest Dexcom G4 Platinum continuous glucose monitoring system. Diabetes Technol Ther. 2015;17:548–54.
Wentholt IM, Maran A, Masurel N, Heine RJ, Hoekstra JB, DeVries JH. Nocturnal hypoglycemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration, and associations. Diabet Med. 2007;24:527–32.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Aboona, F., Zahedi, S., Reddy, S.S.K. (2019). Pseudohypoglycemia. In: McDermott, M. (eds) Management of Patients with Pseudo-Endocrine Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-22720-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-22720-3_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-22719-7
Online ISBN: 978-3-030-22720-3
eBook Packages: MedicineMedicine (R0)